Chiesi is an international research-focused pharmaceutical and healthcare group headquartered in Parma, Italy, with 90 years of experience operating in 31 countries. The company researches, develops, and markets innovative drugs across its main therapeutic areas, with a mission to improve people's quality of life while acting responsibly toward society and the environment. Chiesi Group operates Chiesi Global Rare Diseases, a business unit established in 2020 focused on research, development, and commercialization of treatments for rare and ultra-rare disorders, including lysosomal storage diseases, rare hematology, ophthalmology disorders, and rare immunodeficiencies. The company holds B Corp Certification and is committed to transparency, ethical behavior, diversity, and inclusion across its organization.
Beta · Sourced from candidate reports
Be the first to share your experience with Chiesi Group.
Your reply helps other candidates know what to expect.
